US Patent Issued to ModernaTX on Nov. 3 for "Epstein-barr virus MRNA vaccines" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,033, issued on Nov. 3, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Epstein-barr virus MRNA vaccines" was invented by Sumana Chandramouli (Cambridge, Mass.), Brooke Bollman (Brookline, Mass.), Yen-Ting Lai (Cambridge, Mass.), Guillaume Stewart-Jones (Cambridge, Mass.) and Andrea Carfi (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to Epstein-Barr virus ribonucleic acid vaccines as well as methods of using the vaccines and compositions comprising the vaccines."

The patent was filed on April 13, 2022, under Application No. 18/286,705.

*For further information, including images, charts and tables, please...